OSEBX1 945,84+0,55 %
EQNR367,90+1,77 %
DNB278,10+0,04 %
MOWI204,60−0,10 %
Brent$107,37+2,84 %
Gold$4 577,10−0,68 %
USD/NOK9,3184−0,04 %
EUR/NOK10,9032−0,14 %
SPX7 138,80+0,00 %
NDX27 029,01+0,00 %
LIVE · 09:40 UTC
LINNasdaq$508.6572

LINDE PLC

Commodity & Specialty ChemicalsRules + LLM
Score breakdown
Valuation+3Profitability+35Sentiment+30Risk penalty-8
Quality breakdown
Key fields100Profile62Conclusion99AI synthesis67Observations50

Linde PLC maintains a capital structure with total liabilities of $47.08 billion and total equity of $38.25 billion, supported by $5.06 billion in cash and equivalents. The company's liquidity is characterized as high, though its current ratio of 0.88 indicates that current liabilities exceed current assets, signaling potential short-term liquidity constraints. The debt-to-equity ratio of 0.59 suggests a moderate reliance on debt financing, with long-term debt accounting for the majority of its debt obligations. Profitability metrics show Linde PLC generating $8.92 billion in operating income and $6.90 billion in net income on $33.99 billion in revenue. Return on equity of 18.04% and return on assets of 7.95% indicate strong profitability relative to its equity base, though the price-to-book ratio of 135.77 suggests a significant premium is being paid for the company's book value. These returns are well above the cohort median for the industry, reflecting Linde's efficient operations and pricing power. Linde's business is segmented around the production and delivery of industrial gases, with a focus on on-site plants and pipeline complexes. Geographically, the company serves a global customer base, with demand concentrated in industries that require stable and high-volume gas supply. The company's operations are less inventory-intensive, which reduces working capital requirements but also limits flexibility in response to demand fluctuations. Over the past five years and eight quarters, Linde has demonstrated consistent revenue and profit growth, supported by capital expenditures of $5.26 billion in the latest fiscal year. The company's operating cash flow of $10.35 billion and free cash flow of $5.09 billion reflect strong cash generation, which supports its capital structure and reinvestment strategy. The nine-month cash flow statement shows a $341 million decrease in cash and equivalents, driven by net cash outflows from investing and financing activities. Key risk factors include exposure to general economic downturns, which could reduce customer demand and lead to uncollected receivables or contract terminations. Linde also faces potential asset impairment risks if manufacturing capacity utilization declines. Additionally, the company's current liabilities exceeding current assets raises concerns about short-term liquidity, and the net cash position is negative after subtracting total debt, indicating a reliance on external financing. Recent events include the adoption of new accounting standards related to income tax disclosures, which will impact the company's financial statement disclosures. Linde also reported a $341 million cash outflow for the nine months ended September 30, 2025, driven by capital expenditures and financing activities. Analysts have provided a mean price target of $522.82, with a median of $532.50, and a generally positive outlook, with 21 out of 25 analysts issuing "buy" or "strong buy" ratings.

Profile
CompanyLINDE PLC
ExchangeNasdaq
TickerLIN
CIK0001707925
SICIndustrial Inorganic Chemicals
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity & Specialty Chemicals
AI analysis

Business. Linde PLC operates in the Commodity & Specialty Chemicals industry, producing and supplying industrial gases such as oxygen, nitrogen, and hydrogen through cryogenic and process gas on-site plants and pipeline complexes, primarily generating revenue from long-term contracts with high-volume customers in stable demand environments.

Classification. Linde PLC is classified in the Commodity & Specialty Chemicals industry under the Chemicals business sector, based on rule-based classification with a confidence level of 0.97.

Linde PLC maintains a capital structure with total liabilities of $47.08 billion and total equity of $38.25 billion, supported by $5.06 billion in cash and equivalents. The company's liquidity is characterized as high, though its current ratio of 0.88 indicates that current liabilities exceed current assets, signaling potential short-term liquidity constraints. The debt-to-equity ratio of 0.59 suggests a moderate reliance on debt financing, with long-term debt accounting for the majority of its debt obligations. Profitability metrics show Linde PLC generating $8.92 billion in operating income and $6.90 billion in net income on $33.99 billion in revenue. Return on equity of 18.04% and return on assets of 7.95% indicate strong profitability relative to its equity base, though the price-to-book ratio of 135.77 suggests a significant premium is being paid for the company's book value. These returns are well above the cohort median for the industry, reflecting Linde's efficient operations and pricing power. Linde's business is segmented around the production and delivery of industrial gases, with a focus on on-site plants and pipeline complexes. Geographically, the company serves a global customer base, with demand concentrated in industries that require stable and high-volume gas supply. The company's operations are less inventory-intensive, which reduces working capital requirements but also limits flexibility in response to demand fluctuations. Over the past five years and eight quarters, Linde has demonstrated consistent revenue and profit growth, supported by capital expenditures of $5.26 billion in the latest fiscal year. The company's operating cash flow of $10.35 billion and free cash flow of $5.09 billion reflect strong cash generation, which supports its capital structure and reinvestment strategy. The nine-month cash flow statement shows a $341 million decrease in cash and equivalents, driven by net cash outflows from investing and financing activities. Key risk factors include exposure to general economic downturns, which could reduce customer demand and lead to uncollected receivables or contract terminations. Linde also faces potential asset impairment risks if manufacturing capacity utilization declines. Additionally, the company's current liabilities exceeding current assets raises concerns about short-term liquidity, and the net cash position is negative after subtracting total debt, indicating a reliance on external financing. Recent events include the adoption of new accounting standards related to income tax disclosures, which will impact the company's financial statement disclosures. Linde also reported a $341 million cash outflow for the nine months ended September 30, 2025, driven by capital expenditures and financing activities. Analysts have provided a mean price target of $522.82, with a median of $532.50, and a generally positive outlook, with 21 out of 25 analysts issuing "buy" or "strong buy" ratings.
Key takeaways
  • Linde PLC generates strong profitability with a return on equity of 18.04% and return on assets of 7.95%, supported by high operating and net income margins.
  • The company's capital structure is moderately leveraged, with a debt-to-equity ratio of 0.59 and a current ratio of 0.88, indicating potential short-term liquidity constraints.
  • Linde's business model is centered on long-term contracts and stable demand, with limited inventory and a focus on on-site gas delivery, reducing working capital needs.
  • Analysts are optimistic about Linde's future, with a mean price target of $522.82 and a median of $532.50, reflecting confidence in the company's growth and profitability.
  • Economic downturns pose a material risk to Linde's operations, potentially leading to uncollected receivables, contract terminations, and asset impairments.
  • The company is adopting new accounting standards for income tax disclosures, which will enhance transparency but will not impact its financial performance.
Financial snapshot
PeriodFY2025
CurrencyUSD
Revenue$33.99B
Gross profit
Operating income$8.92B
Net income$6.90B
R&D$147.0M
SG&A$2.08B
D&A
SBC$164.0M
Operating cash flow$10.35B
CapEx$5.26B
Free cash flow$5.09B
Total assets$86.82B
Total liabilities$47.08B
Total equity$38.24B
Cash & equivalents$5.06B
Long-term debt$20.68B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
PeriodGross %Op %Net %FCF %
PeriodAssetsEquityCashDebt
PeriodOCFCapExFCFSBC
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
PeriodGross %Op %Net %FCF %
PeriodAssetsEquityCashDebt
PeriodOCFCapExFCFSBC
Valuation
Market price$508.65
Market cap$240.18B
Enterprise value$257.60B
P/E34.8
Reported non-GAAP P/E
EV/Revenue7.6
EV/Op income28.9
EV/OCF24.9
P/B135.8
P/Tangible book135.8
Tangible book$1.77B
Net cash-$17.42B
Current ratio0.9
Debt/Equity0.6
ROA8.0%
ROE18.0%
Cash conversion1.5%
CapEx/Revenue15.5%
SBC/Revenue0.5%
Asset intensity0.3
Dilution ratio
Risk assessment
Dilution riskUnknown
Liquidity riskHigh
  • Current liabilities exceed current assets.
  • Net cash is negative after subtracting total debt.
  • Dilution risk could not be assessed (basic + diluted share counts missing).
Industry benchmarks
Activity: Chemicals · cohort 2 companies
MetricLINActivity
Op margin26.3%26.3% medp25 26.3% · p75 26.3%top quartile
Net margin20.3%20.3% medp25 20.3% · p75 20.3%bottom quartile
Gross margin48.8% medp25 48.8% · p75 48.8%
R&D / revenue0.4%0.4% medp25 0.4% · p75 0.4%top quartile
CapEx / revenue15.5%15.5% medp25 15.5% · p75 15.5%top quartile
Debt / equity59.0%54.1% medp25 54.1% · p75 54.1%top quartile
Observations
IR observations
  • Analyst estimate (TR.PriceTargetMean): Mean price target = 522.82 USD
  • Analyst estimate (TR.PriceTargetMedian): Median price target = 532.50 USD
  • Analyst estimate (TR.PriceTargetHigh): High price target = 580.00 USD
  • Analyst estimate (TR.PriceTargetLow): Low price target = 381.00 USD
  • Analyst estimate (TR.RecMean): Mean recommendation = 2.04 (1=strong buy, 5=strong sell)
  • Analyst estimate (TR.NumOfStrongBuy): Strong-buy count = 5.00
  • Analyst estimate (TR.NumOfBuy): Buy count = 16.00
  • Analyst estimate (TR.NumOfHold): Hold count = 4.00
  • Analyst estimate (TR.NumOfSell): Sell count = 1.00
  • Analyst estimate (TR.NumOfStrongSell): Strong-sell count = 0.00
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
SEC filingstype companyfacts · CIK 0001707925 · 468 us-gaap concepts
2026-04-29 08:21 UTC#ed4fb7ab
Market quoteclose USD 508.65 · shares 0.47B diluted
no public URL
2026-04-29 08:21 UTC#2c611639
Source: analysis-pipeline (hybrid)Generated: 2026-04-29 08:22 UTCJob: 577c5a92